Analysis, Commentary, Health and Fitness

How Rival Opioid Makers Sought To Cash In On Alarm Over OxyContin’s Dangers

Competing drugmakers
(Source: Kaiser Health News)
CALIFORNIA—(ENEWSPF)—August 6, 2018
By: Fred Schulte

As Purdue Pharma faced mounting criticism over deaths linked to OxyContin, rival drugmakers saw a chance to boost sales by stepping up marketing of similarly dangerous painkillers, such as fentanyl, morphine and methadone, Purdue internal documents reveal.

Proud member of LION Publishers

Purdue’s 1996-2002 marketing plans for OxyContin, which Kaiser Health News made publicthis year for the first time, offer an unprecedented look at how that company spent millions…

Most read stories this week

Take a Survey

ARCHIVES